Meridian Wealth Management’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History
Bought
Maintained
Sold
Other funds holding FBT
BFG
Meridian Wealth Management's FBT Position: Q1 2026 in Review
Meridian Wealth Management held its First Trust NYSE Arca Biotechnology Index Fund (FBT) position steady in Q1 2026 at 3,498 shares worth $702K. The position accounts for 0.02% of the portfolio, ranked #426.
Meridian Wealth Management first reported a position in FBT in Q2 2019 and has held it in 21 quarters since. The position peaked at $758K in Q2 2021. 307 funds tracked by Wall St. Rank hold FBT as of Q1 2026.
- Meridian Wealth Management held 3,498 shares of First Trust NYSE Arca Biotechnology Index Fund worth $702K as of Q1 2026.
- Meridian Wealth Management left its First Trust NYSE Arca Biotechnology Index Fund share count unchanged in Q1 2026.
- First Trust NYSE Arca Biotechnology Index Fund made up 0.02% of Meridian Wealth Management's portfolio in Q1 2026, its #426 holding.
- Meridian Wealth Management first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2019 and has held it in 21 quarters since.
- Meridian Wealth Management's First Trust NYSE Arca Biotechnology Index Fund position peaked at $758K in Q2 2021.
- 307 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2026.
Based on Meridian Wealth Management's 13F filing for Q1 2026, filed 6 May 2026.